InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Van Tornout Jan M, Directeur Médical. Director active across 1 company, notably Tyme Technologies, INC.. Aggregated, 3 filings have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €4k. Activity tracked since 12 August 2021. The latest transaction was disclosed on 17 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
7,022 shares@ US$0.3655.4% of flowCommon StockSEC:0000899243-22-007169:0
Ideal exit: 14 Nov 2022 (T+270)
1,000 shares@ US$1.0522.3% of flowCommon StockSEC:0000899243-21-033112:0
Ideal exit: 9 May 2022 (T+270)
1,000 shares@ US$1.0522.3% of flowCommon StockSEC:0000899243-21-033112
Ideal exit: 9 May 2022 (T+270)
3 of 3 declarations
About Van Tornout Jan M
Jan M. Van Tornout is Acting Chief Medical Officer at Tyme Technologies, Inc. He oversees the medical affairs of the company and ensures that operations comply with medical and ethical standards. His role is crucial for ensuring the safety and efficacy of the company's products.
